Neuroendocrine cells associated with neuroendocrine carcinoma of the breast: Nature and significance

Journal of Clinical Pathology

Volumn 65, Issue 8, 2012, Pages 699-703

  Kawasaki, Tomonori ^a   Mochizuki, Kunio ^a   Yamauchi, Hideko ^b   Inoue, Shingo ^a   Kondo, Tetsuo ^a   Oishi, Naoki ^a   Nakazawa, Tadao ^a   Yamane, Tetsu ^a   Koshimizu, Yoshihito ^a   Tsunoda, Hiroko ^b   Yagata, Hiroshi ^b   Inoue, Masayuki ^a   Inoue, Ayako ^a   Maruyama, Takanori ^a   Fujii, Hideki ^a   Katoh, Ryohei ^a  

^a UNIVERSITY OF YAMANASHI   (Japan)

^b ST LUKE'S INTERNATIONAL HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CHROMOGRANIN A; SYNAPTOPHYSIN;

ADULT; ARTICLE; BREAST CARCINOMA; BREAST EPITHELIUM; CANCER MORPHOLOGY; CASE REPORT; DISEASE ASSOCIATION; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; JAPAN; MASTECTOMY; MYOEPITHELIUM CELL; NEUROENDOCRINE TUMOR; NEUROSECRETORY CELL; PRIORITY JOURNAL;

ADULT; BREAST NEOPLASMS; CARCINOMA, NEUROENDOCRINE; CELL SHAPE; CHROMOGRANIN A; FEMALE; HUMANS; HYPERPLASIA; IMMUNOHISTOCHEMISTRY; NEUROENDOCRINE CELLS; PROGNOSIS; TUMOR MARKERS, BIOLOGICAL; VESICULAR TRANSPORT PROTEINS;

EID: 84864564676     PISSN: 00219746     EISSN: 14724146     Source Type: Journal    
DOI: 10.1136/jclinpath-2012-200765     Document Type: Article

References (37)

1. Ellis IO, Schnitt SJ, Sastre-Garau X, et al. Invasive breast carcinoma. In: Tavassoli FA, Devilee P, eds. World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of the Breast and Female Genital Organs. Lyon: IARC Press, 2003:13-59.
2. Sapino A, Righi L, Cassoni P, et al. Expression of apocrine differentiation markers in neuroendocrine breast carcinomas of aged women. Mod Pathol 2001;14:768-76. (Pubitemid 33069835)
3. Righi L, Sapino A, Marchiò C, et al. Neuroendocrine differentiation in breast cancer: established facts and unresolved problems. Semin Diagn Pathol 2010;27:69-76.
4. Wei B, Ding T, Xing Y, et al. Invasive neuroendocrine carcinoma of the breast: a distinctive subtype of aggressive mammary carcinoma. Cancer 2010;116:4463-73.
5. Azzopardi JG, Muretto P, Goddeeris P, et al. 'Carcinoid' tumours of the breast: the morphological spectrum of argyrophil carcinomas. Histopathology 1982;6:549-69. (Pubitemid 12034527)
6. Weigelt B, Geyer FC, Horlings HM, et al. Mucinous and neuroendocrine breast carcinomas are transcriptionally distinct from invasive ductal carcinomas of no special type. Mod Pathol 2009;22:1401-14.
7. Pearse AG, Coulling I, Weavers B, et al. The endocrine polypeptide cells of the human stomach, duodenum, and jejunum. Gut 1970;11:649-58.
8. Gosney JR, Sissons MC, Allibone RO. Neuroendocrine cell populations in normal human lungs: a quantitative study. Thorax 1988;43:878-82.
9. Lechago J. The endocrine cells of the digestive and respiratory systems and their pathology. In: Bloodworth JMB Jr, ed. Endocrine Pathology: General and Surgical. 2nd edn. Baltimore: Williams & Wilkins, 1982:513-55.
10. Hodges JR, Isaacson P, Wright R. Diffuse enterochromaffin-like (ECL) cell hyperplasia and multiple gastric carcinoids: a complication of pernicious anaemia. Gut 1981;22:237-41. (Pubitemid 11113595)
11. Solcia E, Bordi C, Creutzfeldt W, et al. Histopathological classification of nonantral gastric endocrine growths in man. Digestion 1988;41:185-200. Review. (Pubitemid 19070318)
12. Bordi C, D'Adda T, Azzoni C, et al. Hypergastrinemia and gastric enterochromaffin-like cells. Am J Surg Pathol 1995;19(Suppl 1):S8-19. Review.
13. Aguayo SM, Miller YE, Waldron JA Jr, et al. Brief report: idiopathic diffuse hyperplasia of pulmonary neuroendocrine cells and airways disease. N Engl J Med 1992;327:1285-8.
14. Armas OA, White DA, Erlandson RA, et al. Diffuse idiopathic pulmonary neuroendocrine cell proliferation presenting as interstitial lung disease. Am J Surg Pathol 1995;19:963-70.
15. Gosney JR, Williams IJ, Dodson AR, et al. Morphology and antigen expression profile of pulmonary neuroendocrine cells in reactive proliferations and diffuse idiopathic pulmonary neuroendocrine cell hyperplasia (DIPNECH). Histopathology 2011;59:751-62.
16. Wolfe HJ, Melvin KE, Cervi-Skinner SJ, et al. C-cell hyperplasia preceding medullary thyroid carcinoma. N Engl J Med 1973;289:437-41.
17. Bigner SH, Cox EB, Mendelsohn G, et al. Medullary carcinoma of the thyroid in the multiple endocrine neoplasia IIA syndrome. Am J Surg Pathol 1981;5:459-72. (Pubitemid 11000027)
18. Machens A, Niccoli-Sire P, Hoegel J, et al European Multiple Endocrine Neoplasia (EUROMEN) Study Group. Early malignant progression of hereditary medullary thyroid cancer. N Engl J Med 2003;349:1517-25. (Pubitemid 37255037)
19. Bussolati G, Gugliotta P, Sapino A, et al. Chromogranin-reactive endocrine cells in argyrophilic carcinomas ("carcinoids") and normal tissue of the breast. Am J Pathol 1985;120:186-92. (Pubitemid 16255950)
20. Kimura N, Yoshida R, Shiraishi S, et al. Chromogranin A and chromogranin B in noninvasive and invasive breast carcinoma. Endocr Pathol 2002;13:117-22. (Pubitemid 34828132)
21. Satake T, Matsuyama M. Endocrine cells in a normal breast and non-cancerous breast lesion. Acta Pathol Jpn 1991;41:874-8.
22. Partanen S, Syrjänen K. Argyrophilic cells in carcinoma of the female breast. Virchows Arch A Pathol Anat Histol 1981;391:45-51. (Pubitemid 11136638)
23. Viacava P, Castagna M, Bevilacqua G. Absence of neuroendocrine cells in fetal and adult mammary gland: are neuroendocrine breast tumours real neuroendocrine tumours? Breast 1995;4:143-6.
24. Nesland JM, Lunde S, Holm R, et al. Electron microscopy and immunostaining of the normal breast and its benign lesions. A search for neuroendocrine cells. Histol Histopathol 1987;2:73-7. (Pubitemid 17015122)
25. Cross AS, Azzopardi JG, Krausz T, et al. A morphological and immunocytochemical study of a distinctive variant of ductal carcinoma in-situ of the breast. Histopathology 1985;9:21-37. (Pubitemid 15170638)
26. Tsang WY, Chan JK. Endocrine ductal carcinoma in situ (E-DCIS) of the breast: a form of low-grade DCIS with distinctive clinicopathologic and biologic characteristics. Am J Surg Pathol 1996;20:921-43. (Pubitemid 26250633)
27. Kawasaki T, Nakamura S, Sakamoto G, et al. Neuroendocrine ductal carcinoma in situ (NE-DCIS) of the breastecomparative clinicopathological study of 20 NE-DCIS cases and 274 non-NE-DCIS cases. Histopathology 2008;53:288-98.
28. Kawasaki T, Nakamura S, Sakamoto G, et al. Neuroendocrine ductal carcinoma in situ of the breast: cytological features in 32 cases. Cytopathology 2011;22:43-9.
29. Kawasaki T, Inoue A, Mochizuki K, et al. Neuroendocrine ductal carcinoma in situ, comedo type, of the breast detected by screening mammography: a potentially pre-invasive counterpart of high grade neuroendocrine tumours. Pathology 2012;44:273-5.
30. Kawasaki T, Suda M, Kondo T, et al. Microinvasive neuroendocrine carcinoma arising from a central papilloma of the breast. J Clin Pathol 2011;64:549-51.
31. Kawasaki T, Mochizuki K, Yamauchi H, et al. High prevalence of neuroendocrine carcinoma in breast lesions detected by the clinical symptom of bloody nipple discharge. Breast. In press.
32. Bollito ER, Pacchioni D, Lopez-Beltran A, et al. Immunohistochemical study of neuroendocrine differentiation in primary glandular lesions and tumors of the urinary bladder. Anal Quant Cytol Histol 2005;27:218-24. (Pubitemid 41233498)
33. Hamid QA, Rode J, Flanagan AM, et al. Endocrine differentiation in inflamed urinary bladder epithelium with metaplastic changes. Virchows Arch A Pathol Anat Histopathol 1988;412:267-72. (Pubitemid 18040335)
34. Laitio M, Nevalainen T. Ultrastructure of endocrine cells in metaplastic epithelium of human gall bladder. J Anat 1975;120:219-25.
35. Tsutsumi Y, Nagura H, Osamura Y, et al. Histochemical studies of metaplastic lesions in the human gallbladder. Arch Pathol Lab Med 1984;108:917-21. (Pubitemid 15202910)
36. Kawasaki T, Mochizuki K, Kondo T, et al. Neuroendocrine cell hyperplasia of the breast - Potential precancerous lesion of mammary neuroendocrine carcinoma. In: USCAP Annual Meeting. Mod Pathol/Lab Invest 2012;25(Suppl 2)/
37. 92(Suppl 1):45A.